Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
EBOPIPRANT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
EBOPIPRANT
×
Maximum Phase:
2
First Approval:
None
UNII:
Z1AVZ44TEJ
Molecule Type:
Small molecule
Molecular Formula:
C30H34FN3O5S2
Molecular Weight:
599.75
AlogP:
4.33
PSA:
118.8
HBD:
2.0
HBA:
#RotB:
11.0
Source:
LY-2300559
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
LY-2300559
×
Maximum Phase:
2
First Approval:
None
UNII:
Z572ZBT8XL
Molecule Type:
Small molecule
Molecular Formula:
C26H26O6
Molecular Weight:
434.49
AlogP:
4.91
PSA:
104.06
HBD:
3.0
HBA:
#RotB:
9.0
Source:
PG-760564
(2)
Small molecule
MAP kinase p38 alpha inhibitor
Unknown
Investigational
Unknown
PG-760564
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SCARLET RED
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
SCARLET RED
×
Maximum Phase:
2
First Approval:
None
UNII:
I35E9QU96C
Molecule Type:
Small molecule
Molecular Formula:
C24H20N4O
Molecular Weight:
380.45
AlogP:
7.99
PSA:
69.67
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BMS-919373
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BMS-919373
×
Maximum Phase:
2
First Approval:
None
UNII:
NGB50MQK8N
Molecule Type:
Small molecule
Molecular Formula:
C25H20N6O2S
Molecular Weight:
468.54
AlogP:
4.01
PSA:
123.75
HBD:
2.0
HBA:
#RotB:
6.0
Source:
LY-518674
(2)
Small molecule
Peroxisome proliferator-activated receptor alpha agonist
Unknown
Investigational
Unknown
LY-518674
×
Maximum Phase:
2
First Approval:
None
UNII:
U8I57RC739
Molecule Type:
Small molecule
Molecular Formula:
C23H27N3O4
Molecular Weight:
409.49
AlogP:
3.76
PSA:
97.47
HBD:
2.0
HBA:
#RotB:
9.0
Source:
MBX-2044
(2)
Small molecule
Peroxisome proliferator-activated receptor gamma modulator
Unknown
Investigational
Unknown
MBX-2044
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASPACYTARABINE
(2)
Small molecule
DNA disrupting agent
Unknown
Investigational
Unknown
ASPACYTARABINE
×
Maximum Phase:
2
First Approval:
None
UNII:
JL7V54Z2BR
Molecule Type:
Small molecule
Molecular Formula:
C13H18N4O8
Molecular Weight:
358.31
AlogP:
-3.4
PSA:
197.23
HBD:
6.0
HBA:
#RotB:
6.0
Source:
PALOSURAN
(2)
Small molecule
Urotensin II receptor antagonist
Unknown
Investigational
Unknown
PALOSURAN
×
Maximum Phase:
2
First Approval:
None
UNII:
ULD9ZKE457
Molecule Type:
Small molecule
Molecular Formula:
C25H30N4O2
Molecular Weight:
418.54
AlogP:
3.73
PSA:
77.49
HBD:
3.0
HBA:
#RotB:
6.0
Source:
IZORLISIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
IZORLISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TOMIVOSERTIB
(2)
Small molecule
MAP kinase-interacting serine/threonine-protein kinase 1/2 inhibitor
Unknown
Investigational
Unknown
TOMIVOSERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
U2H19X4WBV
Molecule Type:
Small molecule
Molecular Formula:
C17H20N6O2
Molecular Weight:
340.39
AlogP:
1.63
PSA:
114.93
HBD:
3.0
HBA:
#RotB:
2.0
Source:
SOLABEGRON
(2)
Small molecule
Beta-3 adrenergic receptor agonist
Unknown
Investigational
Unknown
SOLABEGRON
×
Maximum Phase:
2
First Approval:
None
UNII:
55P6YH9O6N
Molecule Type:
Small molecule
Molecular Formula:
C23H23ClN2O3
Molecular Weight:
410.9
AlogP:
4.44
PSA:
81.59
HBD:
4.0
HBA:
#RotB:
9.0
Source:
LXH254
(2)
Small molecule
B-raf/RAF proto-oncogene serine/threonine-protein kinase inhibitor
Unknown
Investigational
Unknown
LXH254
×
Maximum Phase:
2
First Approval:
None
UNII:
15JL80DG6H
Molecule Type:
Small molecule
Molecular Formula:
C25H25F3N4O4
Molecular Weight:
502.49
AlogP:
3.93
PSA:
96.81
HBD:
2.0
HBA:
#RotB:
7.0
Source:
BFPET
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BFPET
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C24H19FP+
Molecular Weight:
357.39
AlogP:
4.45
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
4.0
Source:
(-)-PROPANOLOL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
(-)-PROPANOLOL
×
Maximum Phase:
2
First Approval:
None
UNII:
74MLR03FLC
Molecule Type:
Small molecule
Molecular Formula:
C16H21NO2
Molecular Weight:
259.35
AlogP:
2.58
PSA:
41.49
HBD:
2.0
HBA:
#RotB:
6.0
Source:
BEMCENTINIB
(2)
Small molecule
Tyrosine-protein kinase receptor UFO inhibitor
Unknown
Investigational
Unknown
BEMCENTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
0ICW2LX8AS
Molecule Type:
Small molecule
Molecular Formula:
C30H34N8
Molecular Weight:
506.66
AlogP:
4.88
PSA:
97.78
HBD:
2.0
HBA:
#RotB:
4.0
Source:
NM-404 I-124
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
NM-404 I-124
×
Maximum Phase:
2
First Approval:
None
UNII:
08W354EC17
Molecule Type:
Small molecule
Molecular Formula:
C29H53INO4P
Molecular Weight:
634.63
AlogP:
8.28
PSA:
58.59
HBD:
0.0
HBA:
#RotB:
24.0
Source:
FLUBROBENGUANE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
FLUBROBENGUANE
×
Maximum Phase:
2
First Approval:
None
UNII:
XCG95AYX3B
Molecule Type:
Small molecule
Molecular Formula:
C11H15BrFN3O
Molecular Weight:
304.16
AlogP:
2.17
PSA:
71.13
HBD:
3.0
HBA:
#RotB:
6.0
Source:
DEXELVUCITABINE
(2)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
Unknown
Investigational
Unknown
DEXELVUCITABINE
×
Maximum Phase:
2
First Approval:
None
UNII:
KU8SPJ271W
Molecule Type:
Small molecule
Molecular Formula:
C9H10FN3O3
Molecular Weight:
227.19
AlogP:
-0.59
PSA:
90.37
HBD:
2.0
HBA:
#RotB:
2.0
Source:
OMAVELOXOLONE
(2)
Small molecule
Unknown
Unknown
Approved
Unknown
OMAVELOXOLONE
×
Maximum Phase:
2
First Approval:
None
UNII:
G69Z98951Q
Molecule Type:
Small molecule
Molecular Formula:
C33H44F2N2O3
Molecular Weight:
554.72
AlogP:
6.73
PSA:
87.03
HBD:
1.0
HBA:
#RotB:
2.0
Source:
STX107
(2)
Small molecule
Metabotropic glutamate receptor 5 negative allosteric modulator
Unknown
Investigational
Unknown
STX107
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SPEBRUTINIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
SPEBRUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
DRU6NG543J
Molecule Type:
Small molecule
Molecular Formula:
C22H22FN5O3
Molecular Weight:
423.45
AlogP:
4.25
PSA:
97.4
HBD:
3.0
HBA:
#RotB:
10.0
Source:
MK-0533
(2)
Small molecule
Peroxisome proliferator-activated receptor gamma modulator
Unknown
Investigational
Unknown
MK-0533
×
Maximum Phase:
2
First Approval:
None
UNII:
J17152066B
Molecule Type:
Small molecule
Molecular Formula:
C28H24F3NO6
Molecular Weight:
527.5
AlogP:
6.32
PSA:
86.99
HBD:
1.0
HBA:
#RotB:
9.0
Source:
AMPELOPSIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
AMPELOPSIN
×
Maximum Phase:
2
First Approval:
None
UNII:
KD8QND6427
Molecule Type:
Small molecule
Molecular Formula:
C15H12O8
Molecular Weight:
320.25
AlogP:
0.89
PSA:
147.68
HBD:
6.0
HBA:
#RotB:
1.0
Source:
SCH-486757
(2)
Small molecule
Nociceptin receptor agonist
Unknown
Investigational
Unknown
SCH-486757
×
Maximum Phase:
2
First Approval:
None
UNII:
2HV668N62T
Molecule Type:
Small molecule
Molecular Formula:
C24H23Cl2N3O
Molecular Weight:
440.37
AlogP:
5.39
PSA:
49.25
HBD:
1.0
HBA:
#RotB:
4.0
Source:
EZUTROMID
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
EZUTROMID
×
Maximum Phase:
2
First Approval:
None
UNII:
645R07LF0D
Molecule Type:
Small molecule
Molecular Formula:
C19H15NO3S
Molecular Weight:
337.4
AlogP:
4.44
PSA:
60.17
HBD:
0.0
HBA:
#RotB:
3.0
Source:
AVAROFLOXACIN
(2)
Small molecule
Bacterial DNA gyrase inhibitor
Unknown
Investigational
Unknown
AVAROFLOXACIN
×
Maximum Phase:
2
First Approval:
None
UNII:
070SV15RJA
Molecule Type:
Small molecule
Molecular Formula:
C21H23F2N3O4
Molecular Weight:
419.43
AlogP:
2.96
PSA:
97.79
HBD:
2.0
HBA:
#RotB:
5.0
Source:
DEUTERIUM OXIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
DEUTERIUM OXIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
J65BV539M3
Molecule Type:
Small molecule
Molecular Formula:
H2O
Molecular Weight:
20.03
AlogP:
-0.82
PSA:
31.5
HBD:
0.0
HBA:
#RotB:
0.0
Source:
ROVAFOVIR ETALAFENAMIDE
(2)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
Unknown
Investigational
Unknown
ROVAFOVIR ETALAFENAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
U8S0IC8DY7
Molecule Type:
Small molecule
Molecular Formula:
C21H24FN6O6P
Molecular Weight:
506.43
AlogP:
2.9
PSA:
152.71
HBD:
2.0
HBA:
#RotB:
10.0
Source:
NIDUFEXOR
(2)
Small molecule
Bile acid receptor FXR agonist
Unknown
Investigational
Unknown
NIDUFEXOR
×
Maximum Phase:
2
First Approval:
None
UNII:
CJ1PL0TE6J
Molecule Type:
Small molecule
Molecular Formula:
C27H22ClN3O4
Molecular Weight:
487.94
AlogP:
5.17
PSA:
84.66
HBD:
1.0
HBA:
#RotB:
6.0
Source:
NAPROXEN ETEMESIL
(2)
Small molecule
Cyclooxygenase inhibitor
Unknown
Investigational
Unknown
NAPROXEN ETEMESIL
×
Maximum Phase:
2
First Approval:
None
UNII:
214269U36R
Molecule Type:
Small molecule
Molecular Formula:
C17H20O5S
Molecular Weight:
336.41
AlogP:
2.54
PSA:
69.67
HBD:
0.0
HBA:
#RotB:
6.0
Source:
RESMINOSTAT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
RESMINOSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
1578EUB98L
Molecule Type:
Small molecule
Molecular Formula:
C16H19N3O4S
Molecular Weight:
349.41
AlogP:
1.31
PSA:
91.64
HBD:
2.0
HBA:
#RotB:
6.0
Source:
SB-705498
(2)
Small molecule
Vanilloid receptor antagonist
Unknown
Investigational
Unknown
SB-705498
×
Maximum Phase:
2
First Approval:
None
UNII:
T74V9O0Y2W
Molecule Type:
Small molecule
Molecular Formula:
C17H16BrF3N4O
Molecular Weight:
429.24
AlogP:
4.26
PSA:
57.26
HBD:
2.0
HBA:
#RotB:
3.0
Source:
ENCALERET SULFATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ENCALERET SULFATE
×
Maximum Phase:
2
First Approval:
None
UNII:
7CKZ1Y8K70
Molecule Type:
Small molecule
Molecular Formula:
C58H70Cl2F2N2O13S
Molecular Weight:
1144.17
AlogP:
6.2
PSA:
78.79
HBD:
3.0
HBA:
#RotB:
11.0
Source:
OSI-632
(2)
Small molecule
Vascular endothelial growth factor receptor 2 inhibitor
Unknown
Investigational
Unknown
OSI-632
×
Maximum Phase:
2
First Approval:
None
UNII:
W1B375O5M2
Molecule Type:
Small molecule
Molecular Formula:
C20H24BrF2N5O3S
Molecular Weight:
532.41
AlogP:
3.86
PSA:
109.58
HBD:
3.0
HBA:
#RotB:
10.0
Source:
KD7040
(2)
Small molecule
Nitric oxide synthase, inducible inhibitor
Unknown
Investigational
Unknown
KD7040
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C17H20N6O2S
Molecular Weight:
372.45
AlogP:
2.07
PSA:
77.33
HBD:
1.0
HBA:
#RotB:
8.0
Source:
1
2
…
157
158
159
160
161
162
163
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA